Medicine and Dentistry
Epileptic Seizure
92%
Status Epilepticus
87%
Cancer Stem Cell
63%
Cancer Stem Cell Line
48%
Neoplasm
44%
Long Term Survival
42%
Primary Generalized Epilepsy
40%
Meta-Analysis
38%
Systematic Review
38%
Drug Resistance
37%
Ganglioglioma
37%
Genetic Generalized Epilepsy
29%
Stem Cell
24%
Sodium Valproate
22%
Biological Marker
20%
Recurrent Disease
20%
In Vitro
20%
Lafora Disease
20%
Cohort Effect
19%
Case-Control Study
19%
Diseases
19%
Tonic-Clonic Seizure
18%
Magnetic Resonance Imaging
18%
Comorbidity
17%
Treatment Response
17%
Prognostic Factor
16%
Overall Survival
14%
Metastatic Carcinoma
13%
Lactic Acid
12%
Tumor Recurrence
12%
Methyltransferase
11%
Neurology
11%
Endophenotype
10%
Medicine
10%
Stem Cell Line
9%
Tumor Cell
9%
Doxorubicin
9%
Clear Cell Renal Cell Carcinoma
9%
Multimodality Imaging
9%
Calmodulin Binding
9%
Trastuzumab
9%
Thalamus
9%
Pulvinar
9%
Kleine-Levin Syndrome
9%
Natural Killer Cell
9%
Gelatinase A
9%
Bipolar Disorder
9%
NMR Spectroscopy
9%
Idiopathic Intracranial Hypertension
9%
Hospital Care
9%
Neuroscience
Primary Generalized Epilepsy
100%
Status Epilepticus
79%
Antiseizure Medication
52%
Levetiracetam
44%
Juvenile Myoclonic Epilepsy
43%
Drug Resistance
42%
Genetic Generalized Epilepsy
41%
Meta-Analysis
39%
Lamotrigine
30%
Tonic-Clonic Seizure
28%
Valproic Acid
24%
In Vitro
21%
Epileptic Seizure
21%
Brain Disease
21%
Comorbidity
21%
Generalised Epilepsy
20%
Ictal
20%
Idiopathic Intracranial Hypertension
19%
Temozolomide
19%
Anti-Seizure Medication
18%
Magnetic Resonance Imaging
18%
Isocitrate Dehydrogenase 1
15%
Childhood Absence Epilepsy
15%
Endophenotype
15%
In Vivo
15%
Programmed Cell Death
13%
Astrocytoma
12%
Anticonvulsant
12%
Magnetic Resonance Imaging
12%
Caspase 8
11%
Fas Ligand
11%
Caspase
11%
Methyltransferase
11%
Guanidine
11%
Telomere
11%
Impulsivity
11%
Staining Technique
11%
Progenitor Cell
11%
Drug Therapy
10%
Magnetic Susceptibility
9%
Parallel Imaging
9%
Fas Receptor
9%
Telomerase
9%
Evoked Potential
9%
Glutamic Acid
9%
Cell Membrane
9%
Vitamin C
9%
Tyrosine Kinase Receptor
9%
Brain Ischemia
9%
Cerebral Hemorrhage
9%
Pharmacology, Toxicology and Pharmaceutical Science
Generalised Epilepsy
94%
Epileptic State
69%
Drug Resistance
45%
Malignant Neoplasm
43%
Long Term Survival
40%
Levetiracetam
37%
Lamictal
34%
Sodium Valproate
33%
Chemotherapy
24%
Tonic Clonic Seizure
21%
Recurrent Disease
21%
Idiopathic Intracranial Hypertension
19%
Biological Marker
18%
Myoclonus Epilepsy
17%
Monotherapy
17%
Neoplasm
16%
Combination Therapy
14%
Overall Survival
12%
Methyltransferase
11%
Drug Resistant Epilepsy
11%
Tumor Recurrence
11%
Side Effect
11%
Comorbidity
10%
Diseases
10%
Topiramate
9%
Astrocytoma
9%
microRNA 9
9%
Aldehyde Dehydrogenase
9%
Doxorubicin
9%
Pharmacotherapy
9%
Remission
9%
Medulloblastoma
9%
Bipolar Disorder
9%
Childhood Absence Epilepsy
9%
Randomized Controlled Trial
9%
Tumor Suppressor Protein
9%
Calmodulin
9%
Intervention Study
9%
Papilledema
9%
DNA Methyltransferase
9%
Onset Age
8%
Polyethylene Glycol
8%
Syndrome
7%
Cohort Study
7%
Controlled Clinical Trial
7%
Add on Therapy
6%
Sleep Disorder
6%
Hospital Mortality
6%
Anticonvulsive Agent
5%
